Antibodies 2023
Antibody drugs are developed using genetic engineering and recombinant DNA technology, utilizing living cells and organisms like E. coli, yeast, and mammalian cells. The rise in chronic and life-threatening diseases like asthma, multiple sclerosis, cancer, and heart diseases has bolstered the antibody-drug industry’s growth globally. The report assesses the therapeutic applications of monoclonal antibodies (mAbs) in human medicine, including mAbs combined with cytotoxic agents, such as antibody-drug conjugates.
antibodies-2023-s
